Resultados da pesquisa - Victor Sokolov

Effectiveness of dapagliflozin as an insulin adjunct in type 1 diabetes: a semi-mechanistic exposure-response model Por Victor Sokolov, Victor Sokolov, Tatiana Yakovleva, Robert C. Penland, David W. Boulton, Weifeng Tang

Connect to this object online.

Evaluation of therapeutic strategies targeting BCAA catabolism using a systems pharmacology model Por Veronika Voronova, Victor Sokolov, Victor Sokolov, Yannick Morias, Malin Jonsson Boezelman, Maria Wågberg, Marcus Henricsson, Karl Hansson, Alexey Goltsov, Alexey Goltsov, Kirill Peskov, Kirill Peskov, Kirill Peskov, Monika Sundqvist

Connect to this object online.

A tutorial for model‐based evaluation and translation of cardiovascular safety in preclinical trials Por Victoria Kulesh, Igor Vasyutin, Alina Volkova, Kirill Peskov, Holly Kimko, Victor Sokolov, Ravindra Alluri

Connect to this object online.

A mechanistic modeling platform of SGLT2 inhibition: Implications for type 1 diabetes Por Victor Sokolov, Tatiana Yakovleva, Leonid Stolbov, Robert C. Penland, David Boulton, Joanna Parkinson, Weifeng Tang

Connect to this object online.

Differentiating the Sodium‐Glucose Cotransporter 1 Inhibition Capacity of Canagliflozin vs. Dapagliflozin and Empagliflozin Using Quantitative Systems Pharmacology Modeling Por Victor Sokolov, Tatiana Yakovleva, Lulu Chu, Weifeng Tang, Peter J. Greasley, Susanne Johansson, Kirill Peskov, Gabriel Helmlinger, David W. Boulton, Robert C. Penland

Connect to this object online.

Quantitative Systems Pharmacology: An Exemplar Model‐Building Workflow With Applications in Cardiovascular, Metabolic, and Oncology Drug Development Por Gabriel Helmlinger, Victor Sokolov, Kirill Peskov, Karen M. Hallow, Yuri Kosinsky, Veronika Voronova, Lulu Chu, Tatiana Yakovleva, Ivan Azarov, Daniel Kaschek, Artem Dolgun, Henning Schmidt, David W. Boulton, Robert C. Penland

Connect to this object online.